pI: 5.635 |
Length (AA): 264 |
MW (Da): 27208 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 8
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
30 | 261 | 5tsa (A) | 59 | 305 | 24.00 | 0.000053 | 0.65 | 1.16359 | -0.4 |
40 | 257 | 5tsa (A) | 69 | 301 | 31.00 | 0.00000037 | 0.97 | 1.06556 | 0.29 |
171 | 241 | 1x31 (C) | 21 | 95 | 38.00 | 0.25 | 0.4 | 0.414739 | 1.86 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127397)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G20870 | zinc transporter ZTP29 |
Arabidopsis thaliana | AT3G08650 | putative zinc transporter |
Brugia malayi | Bm1_11530 | ZIP Zinc transporter family protein |
Candida albicans | CaO19.9109 | potential zinc-iron permease similar to S. cerevisiae ZRT3 (YKL175W) |
Candida albicans | CaO19.1534 | potential zinc-iron permease similar to S. cerevisiae ZRT3 (YKL175W) |
Caenorhabditis elegans | CELE_F59A3.4 | Protein F59A3.4 |
Dictyostelium discoideum | DDB_G0286345 | zinc transporter |
Drosophila melanogaster | Dmel_CG13189 | Zinc/iron regulated transporter-related protein 48C |
Escherichia coli | b3040 | zinc transporter |
Entamoeba histolytica | EHI_103680 | metal cation transporter, zinc (Zn2 )-iron (Fe2 ) permease (ZIP) family |
Homo sapiens | ENSG00000133195 | solute carrier family 39, member 11 |
Loa Loa (eye worm) | LOAG_12272 | ZIP Zinc transporter |
Mus musculus | ENSMUSG00000041654 | solute carrier family 39 (metal ion transporter), member 11 |
Mycobacterium tuberculosis | Rv0318c | Probable conserved integral membrane protein |
Mycobacterium ulcerans | MUL_0554 | transcriptional regulatory protein |
Oryza sativa | 4328613 | Os02g0196000 |
Oryza sativa | 4338391 | Os05g0316100 |
Onchocerca volvulus | OVOC100 |
|
Saccharomyces cerevisiae | YKL175W | Zn(2+) transporter ZRT3 |
Schmidtea mediterranea | mk4.000242.05 | Zinc transporter ZIP11 |
Trypanosoma cruzi | TcCLB.511319.30 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
b3040 | Escherichia coli | non-essential | goodall |
CELE_F59A3.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F59A3.4 | Caenorhabditis elegans | larval arrest | wormbase |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.